❓WHAT HAPPENED: Hims announced it will stop offering access to its untested compounded semaglutide pill.
👤WHO WAS INVOLVED: Hims and its woke CEO.
📍WHEN & WHERE: The decision was made following a report by The National Pulse on Friday, February 6th.
💬KEY QUOTE: “We’ve had constructive conversations with stakeholders across the industry.” – Hims
🎯IMPACT: The company aims to continue providing safe, affordable, and personalized care to Americans.
Just one day after The National Pulse’s report on Hims, its woke CEO, and its unproven GLP-1 knockoff drugs, the company has announced it will stop offering access to its compounded semaglutide pill.
The decision comes as Hims states that since launching the pill on its platform, it has engaged in “constructive conversations with stakeholders across the industry.”
As a result, Hims has decided to cease offering this particular treatment.
The announcement follows scrutiny over the company’s preparations and the safety of its products.
This weekend, the firm is set to air a populist-left ad at the Super Bowl, claiming it can bring ordinary consumers the healthcare standards of the hyper-elite for a fraction of the price.
The company’s claims have been widely mocked. They also concerned Trump administration insiders so much that an immediate investigation was ordered this week by Health and Human Services Counsel Mike Stuart, who wrote on X: “Based on a review of the applicable facts, earlier today @HHSOGC referred Hims & Hers Health, Inc. (“Hims”) to the Department of Justice for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions.”
HHS Title 18 covers criminal fraud, false statements, and conspiracy laws used to police abuse of federal health programs.
Based on a review of the applicable facts, earlier today @HHSOGC referred Hims & Hers Health, Inc. (“Hims”) to the Department of Justice for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions.
— HHS General Counsel Mike Stuart (@HHSGCMikeStuart) February 6, 2026
Join Pulse+ to comment below and receive exclusive email analyses.
Article image via Hims press release.
